Associate Director, Corporate FP&A
Revolution Medicines
Summary
Revolution Medicines is seeking an Associate Director of Corporate FP&A to join our growing Finance team. Reporting to the Senior Director, Corporate FP&A, this role will lead core corporate finance processes and deliver the analysis, planning discipline, and decision support needed to guide enterprise priorities with a focus on headcount planning. The Associate Director will partner closely with Finance and business leaders across a global organization to translate operating plans into clear financial insights, strengthen forecasting and reporting, and improve the data foundation for decision making.
Job description
The Opportunity
Revolution Medicines is seeking an Associate Director of Corporate FP&A to join our growing Finance team. Reporting to the Senior Director, Corporate FP&A, this role will lead core corporate finance processes and deliver the analysis, planning discipline, and decision support needed to guide enterprise priorities with a focus on headcount planning. The Associate Director will partner closely with Finance and business leaders across a global organization to translate operating plans into clear financial insights, strengthen forecasting and reporting, and improve the data foundation for decision making.
Responsibilities
- Lead enterprise headcount financial planning and reporting, including the development of headcount assumptions, function-level forecasts, and plan versus actual analysis in close partnership with HR.
- Prepare and lead corporate-level budgets such as non-cash operating expenses and non-operating expenses.
- Prepare monthly and quarterly senior management reporting, including actual versus budget/forecast variance analysis.
- Assist in leading corporate financial planning cycles, including annual budget, quarterly forecasts, and related management reporting.
- Partner with regional Finance colleagues to support planning, forecasting, and reporting across a global operating environment.
- Design, maintain, and enhance models, reports, and workflows associated with financial planning tool to improve planning accuracy, process efficiency, and user adoption.
- Establish reliable data processes and controls for planning and reporting, including data validation, reconciliations, and documentation of key assumptions and logic.
- Support presentations to senior management, ad hoc analyses, and strategic projects with concise, decision-ready financial perspectives.
- Help drive process improvements and efficiencies in areas of financial planning, financial analysis, and production of reporting packages.
- Support ad hoc analyses and special projects, providing timely and accurate financial insights to support organizational initiatives.
Required Skills, Experience and Education
- Bachelor's degree in Finance, Accounting, or related field.
- CPA or MBA preferred.
- 8+ years in progressive finance, corporate finance, and/or FP&A experience supporting a complex organization; life sciences or biopharmaceutical experience is preferred.
- Experience managing headcount planning, workforce forecasts, and related financial analysis in partnership with business leaders and People/HR teams.
- Experience with global expansion preferred.
- Demonstrated experience leading planning, forecasting, financial modeling, management reporting, and variance analysis.
- Working knowledge of GAAP and related financial statements.
- Excel expertise with modeling experience, PowerPoint proficiency.
- Extensive experience utilizing financial planning tools and other business intelligence tools.
- Strong written and oral communication skills.
- Strong analytical thinking and attention to detail and accuracy.
- Strong collaboration skills to work cross-functionally with ability to synthesize viewpoints of different functions, while executing on individual and shared goals.
Requirements
- Bachelor's degree in Finance, Accounting, or related field
- CPA or MBA preferred
- 8+ years in progressive finance, corporate finance, and/or FP&A experience supporting a complex organization
- Life sciences or biopharmaceutical experience preferred
- Experience managing headcount planning, workforce forecasts, and related financial analysis in partnership with business leaders and People/HR teams
- Experience with global expansion preferred
- Demonstrated experience leading planning, forecasting, financial modeling, management reporting, and variance analysis
- Working knowledge of GAAP and related financial statements
- Excel expertise with modeling experience
- PowerPoint proficiency
- Extensive experience utilizing financial planning tools and other business intelligence tools
- Strong written and oral communication skills
- Strong analytical thinking and attention to detail and accuracy
- Strong collaboration skills to work cross-functionally
Benefits
- Competitive cash compensation
- Equity awards
- Health benefits
- Learning and development opportunities
Company overview
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The company is pioneering a new class of therapeutics that target oncogenic RAS mutations, which are among the most common drivers of human cancers. Revolution Medicines employs a unique approach to drug discovery, leveraging deep insights into RAS biology to develop small molecule inhibitors that can address previously undruggable targets. Their pipeline includes multiple clinical-stage candidates designed to inhibit various RAS pathway mutations, with a particular focus on KRAS G12C and other RAS variants. The company's scientific platform combines structural biology, medicinal chemistry, and computational approaches to design highly selective inhibitors. Revolution Medicines aims to transform cancer treatment by developing therapies that can overcome resistance mechanisms and provide durable clinical benefits for patients with RAS-driven malignancies. Their research represents a significant advancement in the field of targeted cancer therapy, addressing one of the most challenging areas in oncology drug development.